CIK: 1605431 - Address: C/o Avalon Mgt. Ltd., Landmark Square, 1St Floor, 64 Earth Close, Grand Cayman, E9 KY1-1107
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1170-2111925510
S%wins577114001426

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/17/15 10:10
3/13/15
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAeris Capital Equity Investments, L.P.E9TS-6,03117.232-350-171,662D-42131043222714-23
12/4/14 19:07
12/2/14
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAeris Capital Equity Investments, L.P.E9TS.m-1,61914.511-112-52,012D-20-162-3-2-1-1118193615
12/2/14 17:06
11/28/14
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAeris Capital Equity Investments, L.P.E9TS.m-19814.541-14-12,124D-20-220-1-1-21-520203814
11/28/14 14:45
11/26/14
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAeris Capital Equity Investments, L.P.E9TS-18514.771-13-12,137D-17-183-200-1-516172210
11/26/14 16:43
11/24/14
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAeris Capital Equity Investments, L.P.E9TS.m-14914.851-1002,150D-19-1950-10-1-21517217
11/25/14 17:57
11/21/14
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAeris Capital Equity Investments, L.P.E9TS-13014.821-902,160D-18-195-9221-2917226
11/24/14 17:45
11/20/14
ADMSAdamas Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAeris Capital Equity Investments, L.P.E9TS-5114.691-402,169D-20-17-1-9-12-1-3-117217

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact